| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CCL3, CCL5, IL-15, IL-1Ra and VEGF compose a reliable algorithm to discriminate classes of adverse events following 17DD-YF primary vaccination according to cause-specific definitions
|
Fradico, Jordana Rodrigues Barbosa
|
|
|
39 |
31 |
p. 4359-4372
|
artikel
|
| 2 |
Clinical and molecular characterization of the first culture-confirmed pediatric fulminant meningococcemia case caused by a serogroup Y clonal complex 23 strain in China
|
Wang, Xiangshi
|
|
|
39 |
31 |
p. 4261-4265
|
artikel
|
| 3 |
COVID-19 related immunization disruptions in Rajasthan, India: A retrospective observational study
|
Jain, Radhika
|
|
|
39 |
31 |
p. 4343-4350
|
artikel
|
| 4 |
COVID-19 vaccination rates vary by community vulnerability: A county-level analysis
|
Brown, Clare C.
|
|
|
39 |
31 |
p. 4245-4249
|
artikel
|
| 5 |
Early influenza vaccination rates decline in children during the COVID-19 pandemic
|
Fogel, Benjamin
|
|
|
39 |
31 |
p. 4291-4295
|
artikel
|
| 6 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
31 |
p. IFC
|
artikel
|
| 7 |
Enterotoxigenic Escherichia coli (ETEC) vaccines: Priority activities to enable product development, licensure, and global access
|
Khalil, Ibrahim
|
|
|
39 |
31 |
p. 4266-4277
|
artikel
|
| 8 |
Extended follow-up of children in a phase2b trial of the GMZ2 malaria vaccine
|
Dassah, Sylvester
|
|
|
39 |
31 |
p. 4314-4319
|
artikel
|
| 9 |
Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines
|
Zimmerman, Richard K.
|
|
|
39 |
31 |
p. 4242-4244
|
artikel
|
| 10 |
Household decision-making for the MenACWY vaccination: How parents and adolescents deal with an adolescent vaccination decision
|
Oostdijk, C.
|
|
|
39 |
31 |
p. 4283-4290
|
artikel
|
| 11 |
Impact of the COVID-19 pandemic on the provision of routine childhood immunizations in Ontario, Canada
|
Piché-Renaud, Pierre-Philippe
|
|
|
39 |
31 |
p. 4373-4382
|
artikel
|
| 12 |
Investigation of the baseline tetanus antibody level and its persistence in a military unit
|
Tong, Libo
|
|
|
39 |
31 |
p. 4328-4334
|
artikel
|
| 13 |
Long-term antibody persistence and exceptional vaccination response on previously SARS-CoV-2 infected subjects
|
Ferrari, Davide
|
|
|
39 |
31 |
p. 4256-4260
|
artikel
|
| 14 |
Maternal transfer of neutralizing antibodies to B. burgdorferi OspA after oral vaccination of the rodent reservoir
|
Phillip, Kathryn
|
|
|
39 |
31 |
p. 4320-4327
|
artikel
|
| 15 |
Measles epidemiology and vaccination coverage in Oromia Region, Ethiopia: Evidence from surveillance, 2011–2018
|
Yitbarek, Kiddus
|
|
|
39 |
31 |
p. 4351-4358
|
artikel
|
| 16 |
Modelling the impact of respiratory syncytial virus (RSV) vaccine and immunoprophylaxis strategies in New Zealand
|
Prasad, Namrata
|
|
|
39 |
31 |
p. 4383-4390
|
artikel
|
| 17 |
Papillomavirus vaccination and Guillain-Barre Syndrome among girls: A cohort study in Spain
|
Martín-Merino, Elisa
|
|
|
39 |
31 |
p. 4306-4313
|
artikel
|
| 18 |
Preclinical evaluation of recombinant HFMD vaccine based on enterovirus 71 (EV71) virus-like particles (VLP): Immunogenicity, efficacy and toxicology
|
Wang, Ziyan
|
|
|
39 |
31 |
p. 4296-4305
|
artikel
|
| 19 |
Should countries switch to using five- or ten-dose rotavirus vaccines now that they are available?
|
Wedlock, Patrick T.
|
|
|
39 |
31 |
p. 4335-4342
|
artikel
|
| 20 |
Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis
|
Smith, Kenneth J.
|
|
|
39 |
31 |
p. 4278-4282
|
artikel
|
| 21 |
Syndromic surveillance of vaccine-associated adverse events in U.S. emergency departments
|
Radhakrishnan, Lakshmi
|
|
|
39 |
31 |
p. 4250-4255
|
artikel
|
| 22 |
The need for broadly protective COVID-19 vaccines: Beyond S-only approaches
|
Poland, Gregory A.
|
|
|
39 |
31 |
p. 4239-4241
|
artikel
|
Tijdschrift beschrijving